List of medicines in France for treatment:
Alternative to Maxius in France
The best equivalent of Maxius in France called Cetavlex 0.5%. Analogue has exactly the same pharmacological group
You can buy Cetavlex 0.5% (alternative to Maxius) in pharmacies of France.
Attention! Always consult to a doctor or pharmacist before using pills or medicines.
Where to buyMedically reviewed by Kovalenko Svetlana Olegovna, PharmD. Last updated on 2020.01.09

Portugal
Ingredients
Tibezonium Iodide
Treatment option
-
-
-
-
-
-
-
-
-
-
Pharmacological group
equal

France
Ingredients
Chlorhexidine Gluconate
Treatment option
Pharmacological group equal
Where to buy Maxius or alternative in France
To buy Maxius or its alternatives in France, we recommend to contact your nearest pharmacy. Call the pharmacy using the number on the map, to find out if Maxius is in stock. Remember to ask the pharmacist about the price of the medicine and the requirement to provide a prescription, many medicines in France are sold strictly according to the doctor's prescription. Show pharmacy near me.
Show pharmacy near me
Pillintrip.com is not a pharmacy!
Advertisements
Advertisements
Other analogues
| Name | Ingredients | Treatment option | Pharmacological group | ||
| Cetavlex 0.5% | 30% | ||||
| Cicajet | 30% | ||||
| Collunovar 0.11% | 30% | ||||
| Daktarin 2% | 30% | ||||
| Duraphat | 30% | ||||
| EludrilPerio 0.2% | 30% | ||||
| Fluocal | 30% | ||||
| Fluorex | 30% | ||||
| Gyno-Daktarin | 30% | ||||
| Hexaspray | 30% | ||||
| Hexatrione 2% | 30% | ||||
| Hexid | 30% | ||||
| Hextril | 30% | ||||
| Hibidil | 30% | ||||
| Hibiscrub 4% | 30% | ||||
| Hibitane 5% | 30% | ||||
| Kenacort Retard | 30% | ||||
| Loramyc | 30% | ||||
| Nasacort | 30% | ||||
| Prexidine 0.12% | 30% | ||||
| Sanogyl | 30% | ||||
| Septivon 1.5% | 30% | ||||
| Zymafluor | 30% | ||||
| Collu-Hextril 0.2% | 30% | ||||
| Ferrostrane 0.68% | 30% | ||||
| Hexétidine Biogaran Conseil 0.1% | 30% | ||||
| Humex mal de gorge | 30% | ||||
| Solutricine Maux de Gorge Biclotymol | 30% |
Advertisements
Advertisements
Advertisements
Advertisements
